Clinical Trials on Herpes Simplex Virus 2 in Spain

Total 95 results

GlaxoSmithKline

Active, not recruiting

A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response

Herpes Zoster

Spain, Canada, Belgium, Finland, Korea, Republic of, Panama, Taiwan
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years

Herpes Zoster

United States, Spain, Czechia
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

Herpes Zoster | Herpes Zoster Vaccine

Canada, Spain, Korea, Republic of, United Kingdom, France, Czechia
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant

Herpes Zoster

Spain, Taiwan, Italy, Canada, Belgium, Finland, Korea, Republic of, Panama, Czechia
GlaxoSmithKline

Completed

Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain

Herpes Zoster

Spain
GlaxoSmithKline

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) Who Had Prior Episode of Shingles

Herpes Zoster

Spain, Panama, Mexico, Russian Federation, Finland, Estonia, Hong Kong, United Kingdom
GlaxoSmithKline

Completed

Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older

Herpes Zoster | Herpes Zoster Vaccine

United States, Australia, Spain, Finland, Germany, Japan, Taiwan, Canada, Sweden, Korea, Republic of, Czechia, Hong Kong, Mexico, Italy, Brazil, Estonia, France, United Kingdom
GlaxoSmithKline

Active, not recruiting

A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults

Herpes Zoster

United States, Australia, Finland, Germany, Japan, Taiwan, Sweden, Spain, Korea, Republic of, Brazil, Mexico, Italy, Canada, Czechia, Estonia, France, Hong Kong, United Kingdom
GlaxoSmithKline

Completed

A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults

Herpes Zoster

United States, Australia, Spain, Finland, Germany, Japan, Taiwan, Sweden, Korea, Republic of, Brazil, Mexico, Canada, Italy, France, Czechia, Estonia, Hong Kong, United Kingdom
GlaxoSmithKline

Completed

Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A

Herpes Zoster

United States, Australia, France, Spain, Finland, Estonia, Russian Federation, Taiwan, Belgium, Korea, Republic of, Czechia, Germany, Hong Kong, Israel, Turkey, United Kingdom, Greece, Romania, Netherlands, Italy, South Africa, Ca... and more
GlaxoSmithKline

Completed

Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older

Herpes Zoster

United States, Australia, Spain, Finland, Germany, Japan, Taiwan, Canada, Sweden, Korea, Republic of, Czechia, Hong Kong, Mexico, Italy, Brazil, Estonia, France, United Kingdom
GlaxoSmithKline

Completed

Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.

Herpes Zoster

United States, Australia, Germany, Spain, Finland, Japan, Taiwan, Sweden, Korea, Republic of, Hong Kong, Mexico, Canada, Italy, France, Brazil, Estonia, United Kingdom, Czechia
GlaxoSmithKline

Completed

Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects

Prophylaxis for Herpes Simplex

Austria, Germany, Belgium, United States, Australia, Canada, Denmark, France, Puerto Rico, South Africa, Spain, Switzerland
GlaxoSmithKline

Completed

Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers

Herpes Zoster

France, Spain, Taiwan, Belgium, Singapore, United States, Hong Kong, Russian Federation, Finland, Korea, Republic of, Czechia, Australia, Canada, Sweden, Poland, United Kingdom, Panama, Italy, Turkey, Pakistan, New Zealand
GlaxoSmithKline

Completed

Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old

Herpes Simplex

United States, Australia, Spain, Romania, United Kingdom, Belgium, Canada, Estonia, France, Hungary, New Zealand, Sweden, Netherlands, Norway, Greece, Denmark, Iceland, Lithuania
GlaxoSmithKline

Active, not recruiting

A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes

Herpes Simplex

Germany, United States, Belgium, Canada, Spain, United Kingdom, Estonia, Australia
GlaxoSmithKline

Active, not recruiting

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

Herpes Genitalis

United States, France, Italy, Spain, Finland, United Kingdom
GlaxoSmithKline

Recruiting

A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

Herpes Zoster

Italy, Spain, United Kingdom, France
Hospital del Río Hortega

Completed

Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study) (DECORE)

SARS-CoV 2 | COVID

Spain
Hospital Clinic of Barcelona
Barcelona Institute for Global Health; University of Barcelona; Universitat Politècnica... and other collaborators

Enrolling by invitation

An Educational Self-tracking Tool for Identification of SARS-CoV-2 Risk Transmission (TrackU)

Transmission | Sars-CoV-2 Infection | Empowerment

Spain
Parc de Salut Mar
Universitat Pompeu Fabra

Completed

Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes (MARZINC)

Zinc Deficiency | Sars-CoV-2 Infection

Spain
Biosearch S.A.

Active, not recruiting

Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly

Elderly | SARS CoV-2 Infection

Spain
Hipra Scientific, S.L.U
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta; Fundación FLS... and other collaborators

Completed

A Phase III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults.

SARS CoV 2 Infection

Spain, Turkey
Complejo Hospitalario Universitario de Albacete

Recruiting

Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19). (COVIDIOL)

SARS-CoV 2 Pneumonia

Spain
GlaxoSmithKline

Completed

A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022

Herpes Zoster

United States, Australia, Germany, Spain, Japan, Taiwan, Sweden, Korea, Republic of, Hong Kong, Mexico, Canada, France, Italy, Brazil, Estonia, United Kingdom, Czechia, Finland
Hospital de Mataró

Recruiting

Eficacia Ventilatoria y Remolacha

Fatigue | SARS CoV 2 Infection | Muscle Disorder

Spain
Hospital de Mataró

Unknown

Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19) (SERO-MARES)

SARS-CoV 2 | Covid19 | COVID | Corona Virus Infection

Spain
Fundacion para la Investigacion Biomedica del Hospital...

Completed

Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19

Type 2 Diabetes

Spain
University of Valladolid
Instituto de Salud Carlos III; Sanidad de Castilla y León

Recruiting

Glycophosphopeptical AM3 A Potential Adjuvant in the Treatment of SARS-CoV-2

SARS-CoV-2 Infection

Spain
Instituto de Investigación Hospital Universitario...

Completed

Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19

SARS-CoV-2 Infection

Spain
Rosa Tarrago
Dentaid SL

Completed

Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19

COVID-19 | SARS-CoV-2 Infection

Spain
Hipra Scientific, S.L.U
Veristat, Inc.; Asphalion; VHIR

Recruiting

Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.

SARS CoV 2 Infection

Spain
European University of Madrid

Unknown

Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance

Covid19- Coronavirus- Sars-cov-2

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Escola L'Horitzó; Escola John Talabot

Completed

Rapid Screening Circuit of COVID 19 in Schools, Pilot Study

SARS-CoV-2 (COVID-19)

Spain
Pharmamel S.L.
Instituto de Investigación Hospital Universitario La Paz; Hospital Universitario...

Completed

Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19 (MELCOVID)

COVID-19 | Coronavirus Infection | SARS-CoV 2

Spain
Igenomix

Unknown

Case Series Study to Detect SARS-CoV-2 in Semen of COVID-19 Patients (COVID-19CAST)

SARS-CoV-2

Spain
Fundación para la Investigación del Hospital Clínico...

Unknown

LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION (INC-CVD-202001)

Pulmonary Fibrosis

Spain
Consorci Sanitari de Terrassa
Institut Català de la Salut

Recruiting

Antihistamines, Amantadine and Evolution of the SARS-CoV-2 Infection

COVID-19

Spain
Fundacio d'Investigacio en Atencio Primaria Jordi...
Fundació Institut Germans Trias i Pujol; Institut Catala de Salut; IrsiCaixa

Recruiting

Professional's Health in Epidemiological Crisis Covid-19 (ProHEpiC-19)

COVID-19 | SARS-CoV-2

Spain
Instituto de Investigación Marqués de Valdecilla
Hospital Universitario de Canarias; Hospital Universitario Marqués de Valdecilla and other collaborators

Recruiting

Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry (RegCOVID19)

SARS-CoV-2

Spain
Instituto de Investigación Hospital Universitario...

Completed

Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. (MeCOVID)

Coronavirus Infection | SARS-CoV 2 | Covid19

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Festivals per la Cultura Segura AIE

Completed

Incidence of Infection Reported by COVID-19 in Attendees of a Commercial Music Concert

Covid-19 (SARS-CoV-2)

Spain
Laboratorios Hipra, S.A.

Completed

Safety and Immunogenicity Study of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers (COVID-19)

Covid19 | SARS CoV 2 Infection

Spain
Universidad Europea de Madrid

Recruiting

Addressing Post-COVID-19 Musculoskeletal Symptoms

COVID-19 | Pain | Exercise | Telemedicine | SARS-CoV-2 | Musculoskeletal Disease

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Dr. Bonaventura Clotet Sala; Dr. Josep Mª LLibre Codina; Dr. Boris Revollo Barriga and other collaborators

Completed

Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures

COVID-19 (SARS-CoV-2)

Spain
Hospitales Universitarios Virgen del Rocío

Active, not recruiting

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed

HIV Infection | SARS-CoV-2 RNA Vaccines

Spain
Hipra Scientific, S.L.U

Completed

A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

Influenza, Human | SARS CoV 2 Infection

Spain
AlloVir

Terminated

Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (Prevent)

BK Virus Infection | Epstein-Barr Virus Infections | Cytomegalovirus Infections | Adenovirus Infection | JC Virus Infection | Human Herpes Virus-6 Infection

Korea, Republic of, United States, Spain, France, Turkey, Australia, United Kingdom, Italy, Canada, Belgium
Parc Taulí Hospital Universitari

Recruiting

Impact of Sleep Disorders on Innate Immunity in COVID-19 Patients

SARS CoV 2 Infection | Apnea, Obstructive Sleep

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Germans Trias i Pujol Hospital; Grifols Biologicals, LLC; Banc de Sang i Teixits and other collaborators

Completed

Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients

SARS-CoV-2 Infection | Safety and Efficacy

Spain

Clinical Trials on Herpes Simplex Virus 2 in Spain

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations